OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 141 - 150 of 716 studies

Cardiovascular

BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT Trial) (BACKBEAT)

This is a multi-national, randomized, double-blinded study to evaluate the safety and effectiveness of AVIM therapy in patients with uncontrolled hypertension with a previously implanted Medtronic Astra/Azure pacemaker. Over 500 participants will be recruited across 100 sites in UK, Europe and US. AVIM is an investigational therapy that can be added to a pacemaker to allow for specific settings that may help with the treatment of hypertension. The study will be performed in three phases, Screening/Run-In, Randomised double-blind and Randomised ...

GO TO STUDY Go

Cardiovascular

Thoraflex Hybrid and Relay Extension Post-Approval Study. (EXTEND-001)

Terumo Aortic is a global medical device company dedicated to developing solutions for aortic and peripheral vascular disease. The purpose of this study is to gather further information on the use of the Thoraflex Hybrid device alone and in combination with the RelayPro NBS Stent-graft; to treat aortic disease affecting the aortic arch and descending aorta with or without involvement of the ascending aorta. Both devices received CE certification, demonstrating conformity to applicable EU requirements. The Thoraflex Hybrid is ...

GO TO STUDY Go

Eye

POLARIS (SB-SC-001): An Observational Human Study in Pediatric and Adult Subjects to Follow the Progression of Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene (Polaris (SB-SC-001))

This is a prospective, observational, non-interventional, multi-center, global clinical study of subjects with early to advanced stage STGD1 caused by bi-allelic likely pathogenic or pathogenic variants in the ABCA4 gene, confirmed genotypically by an accredited genotyping laboratory. The study will consist of 6 visits over a 96-week study period: Visit 1 (Screening Visit), Visit 2 (Week 16), Visit 3 (Week 32) Visit 4 (Week 48), Visit 5 (Week 72), and Visit 6 (Week 96). Subjects who discontinue the study early will ...

GO TO STUDY Go

Cardiovascular Stroke

'Pill-in-Pocket' Oral Anticoagulation Responding to Atrial Fibrillation Episodes Guided by Continuous Rhythm Monitoring and Automated Smartphone Alerts (RESPOND-AF)

Atrial Fibrillation (AF) is the most common cardiac arrhythmia and carries an increased risk of stroke. Stroke risk is commonly assessed using the CHA2DS2-VASC scoring system. To reduce stroke risk, guidelines advise AF patients with higher CHA2DS2-VASC scores be treated with oral anticoagulation (OAC), also known as blood thinning medication. OAC reduces the stroke risk, however it also increases the risk of bleeding episodes, which can be major and life-threatening. AF patterns can vary between patients. One patient may have only one ...

GO TO STUDY Go

Injuries and accidents

A double-blind placebo-controlled study with an open-label pilot phase, assessing the efficacy, tolerability and safety of EU-C-001 in patients with moderate to severe traumatic brain injury (PANGEA)

Traumatic Brain Injury (TBI) is caused by a trauma to the head from a force outside the body, like an accident or fall. Around one million people visit Accident and Emergency each year following a head injury. Although many of these people will experience no lasting effects, others will be left with varying degrees of damage that can have devastating and lifelong consequences. Moderate head injury is defined as loss of consciousness between 15 minutes and six hours, or a ...

GO TO STUDY Go

Injuries and accidents

ODD SOCKS Study- Outcomes of Displaced Ditsal tibial fractures- Surgery Or Casts in KidS Study

Broken ankles in children often involve the area from which the bone grows – the growth plate. Following growth plate injuries, the growth of the main shin bone in the lower leg (the tibia) can be altered permanently, which can cause the bone to not grow at all, or to grow wonky. The younger the child at the time of injury (i.e. the more they have to grow) the worse the problem may get once the child has fully grown. ...

GO TO STUDY Go

Cancer and neoplasms Mental health

Harnessing Adaptive Body Mindsets to Improve Outcomes in Childhood Cancer Survivors (EMBody)

Survivors of childhood cancer experience impaired health-related quality of life, psychological distress, and pain. A previously developed body mindset intervention has improved health-related quality of life and symptom distress in adult cancer patients. In the current research, we will examine whether a body mindset intervention can instil adaptive body mindsets, boost resilience, and improve physical and psychological functioning in survivors of childhood cancer. Survivors of childhood cancer will be randomised to the body mindset intervention or an active attention control group. ...

GO TO STUDY Go

Oral and Gastrointestinal

GONDOMAR: Goals, Needs and outcome Determinants Of Multimodal therapy in Perianal Crohn's fistula - A multicentre cohort study (GONDOMAR)

Perianal fistula in Crohn's Disease (CD-pAF) is an abnormal tunnel that develops between the end of the bowel and the skin near the anus. It affects one third of Crohn's Disease (CD) patients causing significant morbidity and poor quality of life. Patients with CD-pAF are treated with several combined approaches involving medical and various surgical techniques with high failure rates (around 50%). The study will provide an evidence base to identify predictors of fistula healing, potentially modifiable factors, ...

GO TO STUDY Go

Oral and Gastrointestinal

Optimisation before Crohn's surgery using Exclusive Enteral Nutrition (OCEaN)

Crohn’s disease is a lifelong inflammatory illness that causes people to have severe stomach pains, chronic diarrhoea, and suffer weight loss. There is no cure. Crohn’s disease causes inflammation, ulceration, bleeding and narrowing of the digestive system. People can have periods of good health (“remission”) and times when symptoms are more active (“flare ups” or “relapses”). Medications can help keep it in remission, however one third of people will need surgery to remove/repair part of their diseased gut at some ...

GO TO STUDY Go

Inflammatory and immune system

Pain Phenotypes and their Underlying Mechanisms in Inflammatory Arthritis (PUMIA)

Controlling persistent pain is a significant unmet need for people living with Inflammatory arthritis (IA). There is emerging evidence that patients with IA exhibit different types of pain and central sensitisation contributes significantly to chronic pain. The treatment for different pain types will differ. One way in which we might rapidly improve the treatment of pain in IA is by identifying an individual’s pain type in the clinic, then tailor their pain treatment accordingly. Currently this is not routine practice and ...

GO TO STUDY Go